[go: up one dir, main page]

DE60023321D1 - Zusammensetzung gegen Coccidiose - Google Patents

Zusammensetzung gegen Coccidiose

Info

Publication number
DE60023321D1
DE60023321D1 DE60023321T DE60023321T DE60023321D1 DE 60023321 D1 DE60023321 D1 DE 60023321D1 DE 60023321 T DE60023321 T DE 60023321T DE 60023321 T DE60023321 T DE 60023321T DE 60023321 D1 DE60023321 D1 DE 60023321D1
Authority
DE
Germany
Prior art keywords
composition
composition against
against coccidiosis
coccidiosis
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023321T
Other languages
English (en)
Inventor
Shoaa Abdul-Rahman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEW PHARMA RES SWEDEN LUND AB
Original Assignee
NEW PHARMA RES SWEDEN LUND AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEW PHARMA RES SWEDEN LUND AB filed Critical NEW PHARMA RES SWEDEN LUND AB
Application granted granted Critical
Publication of DE60023321D1 publication Critical patent/DE60023321D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
DE60023321T 2000-12-04 2000-12-04 Zusammensetzung gegen Coccidiose Expired - Lifetime DE60023321D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00850205A EP1210950B1 (de) 2000-12-04 2000-12-04 Zusammensetzung gegen Coccidiose

Publications (1)

Publication Number Publication Date
DE60023321D1 true DE60023321D1 (de) 2006-03-02

Family

ID=8175689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023321T Expired - Lifetime DE60023321D1 (de) 2000-12-04 2000-12-04 Zusammensetzung gegen Coccidiose

Country Status (6)

Country Link
EP (1) EP1210950B1 (de)
CN (1) CN1210064C (de)
AT (1) ATE306940T1 (de)
AU (1) AU2002224308A1 (de)
DE (1) DE60023321D1 (de)
WO (1) WO2002045751A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2683527C (en) * 2007-04-19 2014-12-30 Jeroen De Gussem Feed or pharmaceutical composition comprising apramycin or an adequate salt thereof
CN103018440B (zh) * 2012-11-23 2015-09-16 河南科技学院 一种氯羟吡啶胶体金层析检测试纸条或卡

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140315A (en) * 1966-07-27 1969-01-15 Pfizer & Co C Animal feeds
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
ES2145102T3 (es) * 1993-09-09 2000-07-01 Takeda Chemical Industries Ltd Formulacion que comprende una sustancia antibacteriana y una sustancia antiulcerosa.
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
AU2002224308A1 (en) 2002-06-18
ATE306940T1 (de) 2005-11-15
WO2002045751A1 (en) 2002-06-13
EP1210950B1 (de) 2005-10-19
CN1482920A (zh) 2004-03-17
CN1210064C (zh) 2005-07-13
EP1210950A1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
BR0211390A (pt) Tratamento de infecções da unha com no
TW200505483A (en) New medicament compositions based on anticholinergically-effective compounds and β-mimetics
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
SE0301886D0 (sv) New use V
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
WO2002102351A3 (en) Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution
IL181909A0 (en) Phosphoindoles as hiv inhibitors
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
MX2007001953A (es) Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
SE0004101D0 (sv) New use
SE0000303D0 (sv) Novel compounds
ATE306940T1 (de) Zusammensetzung gegen coccidiose
BR0206087A (pt) Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias
SE0102641D0 (sv) Novel compounds

Legal Events

Date Code Title Description
8332 No legal effect for de